Clinical trial
A Phase II Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer
NCT00055419 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2003
- Completion date
- August 31, 2004
- Enrollment
- 744 (actual)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.